SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 187 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $22 | -71.8% | 17,264 | -30.6% | 0.00% | -80.0% |
Q4 2022 | $78 | -99.9% | 24,880 | +63.9% | 0.01% | -16.7% |
Q4 2021 | $114,000 | -46.0% | 15,176 | +12.1% | 0.01% | -47.8% |
Q4 2020 | $211,000 | +5.0% | 13,543 | -36.2% | 0.02% | -32.4% |
Q3 2020 | $201,000 | -54.6% | 21,232 | -57.0% | 0.03% | -33.3% |
Q2 2020 | $443,000 | +321.9% | 49,426 | +293.9% | 0.05% | +410.0% |
Q4 2019 | $105,000 | -79.6% | 12,548 | -77.9% | 0.01% | -75.0% |
Q3 2019 | $514,000 | +111.5% | 56,760 | +123.2% | 0.04% | +185.7% |
Q1 2019 | $243,000 | +88.4% | 25,430 | +126.7% | 0.01% | +100.0% |
Q4 2018 | $129,000 | -45.6% | 11,215 | -32.7% | 0.01% | -30.0% |
Q2 2018 | $237,000 | -67.4% | 16,662 | -56.5% | 0.01% | -74.4% |
Q1 2018 | $727,000 | – | 38,284 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |